Cargando…
Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Diseases
Although recent progress in medicine has substantially reduced cardiovascular diseases (CVDs)-related mortalities, current therapeutics have failed miserably to be beneficial for all patients with CVDs. A wide array of evidence suggests that newly-introduced cell-free treatments (CFTs) have more rel...
Autores principales: | Daneshi, Nahid, Bahmaie, Nazila, Esmaeilzadeh, Abdolreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428475/ https://www.ncbi.nlm.nih.gov/pubmed/36043403 http://dx.doi.org/10.22074/cellj.2022.7643 |
Ejemplares similares
-
47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study)
por: Daneshi, Nahid, et al.
Publicado: (2022) -
Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study
por: Esmaeilzadeh, Abdolreza, et al.
Publicado: (2021) -
Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer
por: Marofi, Faroogh, et al.
Publicado: (2017) -
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
por: Hadiloo, Kaveh, et al.
Publicado: (2023) -
Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments
por: Schooling, C.M., et al.
Publicado: (2018)